中文产业新闻精选评分67Chinese source
NMPA与FDA相继批准匹妥布替尼用于CLL/SLL一线治疗
【获批资讯】中美相继批准！匹妥布替尼为CLL/SLL一线治疗带来新选择
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
【获批资讯】中美相继批准！匹妥布替尼为CLL/SLL一线治疗带来新选择
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.